$33.37
0.02[0.06%]
At close: Apr 26
$33.37
0[0.00%]
After Hours: 4:20PM EDT
Kymera Therapeutics
(NASDAQ:KYMR)Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary
Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.
| Open | $33.750 |
| Close | $33.370 |
| Volume / Avg. | 452.364K / 654.847K |
| Day Range | 33.215 - 34.140 |
| 52 Wk Range | 9.600 - 45.310 |
| Market Cap | $2.048B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 38 |
| Short Interest | 16.6% |
| Days to Cover | 12.98 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Kymera Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Kymera Therapeutics (KYMR) stock?
You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.
Who are Kymera Therapeutics's (KYMR) competitors?
Other companies in Kymera Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
What is the target price for Kymera Therapeutics (KYMR) stock?
The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Oppenheimer on Monday, April 22, 2024. The analyst firm set a price target for 53.00 expecting KYMR to rise to within 12 months (a possible 58.83% upside). 21 analyst firms have reported ratings in the last year.
Current Stock Price for Kymera Therapeutics (KYMR)?
The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $33.37 last updated April 26, 2024 at 4:20 PM EDT.
Does Kymera Therapeutics (KYMR) pay a dividend?
There are no upcoming dividends for Kymera Therapeutics.
When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?
Kymera Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Kymera Therapeutics (KYMR) going to split?
There is no upcoming split for Kymera Therapeutics.
What sector and industry does Kymera Therapeutics (KYMR) operate in?
Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.